Rockwell Medical, Inc. (RMTI)
NASDAQ: RMTI · Real-Time Price · USD
7.50
-0.02 (-0.27%)
At close: Aug 19, 2026, 4:00 PM EDT
7.50
0.00 (0.00%)
After-hours: Aug 19, 2026, 4:10 PM EDT
Rockwell Medical Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for Rockwell Medical stock have an average target of $20, which predicts a 166.67% increase from the current stock price of 7.5.
Price Target: $20 (+166.67%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Rockwell Medical stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Aug '25 | Nov '25 | Jan '26 | Mar '26 | May '26 | Jul '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 1 | 1 | 1 | 1 | 1 |
| Buy | 2 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Maxim Group | Maxim Group | Buy Maintains $40 → $20 | Buy | Maintains | $40 → $20 | +166.67% | Aug 19, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $20 | Buy | Reiterates | $20 | +166.67% | Jul 9, 2026 |
Financial Forecast
Revenue This Year
72.47M
from 69.26M
Increased by 4.64%
Revenue Next Year
78.29M
from 72.47M
Increased by 8.03%
EPS This Year
61.60
EPS Next Year
72.60
from 61.60
Increased by 17.86%
EPS and Forward PE are based on non-GAAP adjusted numbers.